Introduction
Chronic hypertension has a profoundly detrimental effect on cerebral circulation and brain function. For experimental approaches to study hypertension, the spontaneously hypertensive stroke prone rat strain (SHR-SP) proved to be an apt animal model to investigate the consequences of prevailing hypertension on behavior, neuronal integrity and cerebrovascular parameters. Preliminary studies demonstrated that chronic hypertension in 60 weeks old SHR-SP evoked microvascular pathology such as capillary basement membrane thickening and collagen deposits in the basement membrane (Farkas et microvascular breakdown directly stem from chronic hypertension or is it caused by a neurogenic derangement of calcium homeostasis secondary to hypertension? To resolve these questions, we analyzed the cerebral capillary ultrastructure of two age groups (40 weeks old and 60 weeks old) of hypertensive and normotensive rats. Furthermore, we applied a long-term treatment of two dihydropyridine type calcium channel blockers nimodipine and nifedipine on additional experimental groups.
The use of dihydropyridine type calcium channel blockers as anti-aging treatment was based on the finding that calcium influx through voltage sensitive calcium channels appeared to be a major contributor to the dysregulation of neuronal calcium concentration during aging (Schuurman and Traber, 1994; Disterhoft et al., 1996; Luiten et al., 1996) . The typical, agingrelated decline of neural functions (memory capacity, sensorimotor functions) can stem from the imbalance of the intracellular calcium homeostasis, which became a target of pharmacological treatment . Nimodipine and nifedipine can protect cellular integrity by binding to the L-type calcium channels thus blocking the potentially harmful calcium influx to cells. We aimed at making use of the unique properties of the two drugs that they penetrate the blood-brain barrier (BBB) (Janicki et al., 1988; Larkin et al., 1992; Uchida et al., 1997) and can act on neural elements (Scriabine and van den Kerckhoff, 1988). Nimodipine does not affect blood pressure, while nifedipine lowers blood pressure in the here used concentration. Based on the treatments, we evaluated the ultrastructural lesions of the cerebral capillary basement membrane in the frontal cortex of 60 weeks old SHR-SP rats and examined the potentially protective effects of the drugs on the cerebral microvasculature.
Materials and methods
The study was designed to test the effect of aging and the potentially beneficial effects of two L-type calcium channel antagonists, nifedipine and nimodipine on the ultrastructure of cerebral capillaries in male hypertensive rats (SHR-SP, breeder: Møllegaard, Skønevønd, Denmark). In order to assess age-related vascular malformations, four groups of rats were used. These groups were the following: 40-week old SHR-SP rats (SP-40; n=6), 40-week old Wistar Kyoto rats (WKY-40; n=6), 60-week-old WKY rats (WKY-60-plac; n=6) and 60-weelold SHR-SP rats (SP-60-plac; n=8). The WKY animals served as normotensive controls. The animals were group-housed, lived under a standard 12 h light-dark cycle and had access to water and food ad libitum.
The behavioral profile of the animals was characterized by a small open field test, a novelty-induced behavioral arousal paradigm. The rats were individually placed into a new cage (24.5 x 24.5 x 30 cm) and were observed for 60 min on week 40 (WKY-40, SP-40) or
week 60 (WKY-60, SP-60). The actual behavioral activity pattern they were displaying (rearing, grooming, sniffing, walking, immobility) was registered every 10 seconds. A behavioral score was calculated for each kind of explorative activity, which reflected how often the animal showed that particular behavior in the frame of the 60 min observation time.
The systolic blood pressure values (SBP) of groups WKY-40 and SP-40 were taken on week 40 before sacrifying the animals. The SBP of groups WKY-60-plac and SP-60-plac were repeatedly measured on every fourth week between the age of 40 and 60 weeks. The SBP values were assessed with the tail-cuff method on animals slightly anesthetized by ether. Then the rats were anesthetized by an i.p. overdose of sodium pentobarbital and sacrificed by a transcardiac perfusion of physiological saline containing 1 % heparin followed SBP was also measured on every fourth week and the last value was used for later correlation analysis. Three groups of SHR-SP rats were used: 6 animals were fed with nifedipine-containing chow (SP-60-nife) and 6 animals with nimodipine-containing food (SP-60-nimo). Each of these groups had their normotensive WKY controls, (WKY-60-nife, n=6;
WKY-60-nimo, n=6). The food and water intake of the animals, as well as their body weight was regularly monitored to verify comparable drug intake of the separate groups. Because of group housing, the food and water intake of individual animals was calculated by dividing the absolute amount of food and water consumed in a cage by the number of animals in the cage. At the age of 60 weeks, the animals were anesthetized, perfused, and their brains post-fixed as described above. 
Results
The analysis of the novelty-induced exploration showed that two of the behavioral parameters, namely rearing and grooming, significantly differed between groups. When comparing SP-40 and SP-60-plac, the difference in capillary basement membrane pathology appeared to be more pronounced than that seen in the normotensive WKY rats.
Capillaries with BMT occurred three times more frequently in the SP-60-plac than in the SP-40 and the ratio of fibrosis doubled. An increased percentage of microvessels with degenerating pericytes was also found, which was similar to the WKY groups.
Hypertension-related microvascular degeneration could be investigated by evaluating the differences between the SHR-SP and WKY animals ( The graphs seen in Figure 5 .6.D, E & F also characterize the relationship between microvascular morphological degeneration and SBP. (Here, not only the placebo experimental groups but also the treated groups, which are described in detail bellow, were plotted.) BMT and fibrosis showed a positive and significant correlation to SBP while the percentage of microvessels with degenerative pericytes appeared to be independent of SBP. The protective effects of nimodipine and nifedipine on cortical capillary ultrastructure can be visualized if we compare control and treated animals ( Fig. 5.6.A, B & C) . In WKY, the influence of either of the two drugs on BMT or fibrosis could not be demonstrated. However, nifedipine appeared to be able to decrease pericytic degeneration in WKY-60-nife when compared to WKY-60-plac. Thus, it seems that at physiologically optimal SBP values, nimodipine and nifedipine do not alter the ultrastructure of the capillary basement membrane but nifedipine appears to be a drug that acts on pericytes. Treatment of the hypertensive animals with the two drugs yielded to remarkable improvement in capillary morphology.
Nimodipine decreased the incidence of BMT from 40 % (SP-60-plac) to 33 % (SP-60-nimo) but the compound had no significant effect either on fibrosis, or on degenerating pericytes.
Nifedipine treatment led to observations similar to that of nimodipine. BMT was significantly decreased in SP-60-nife while fibrosis was unaffected. Interestingly, nifedipine improved the condition of pericytes (SP-60-nife), which finding was not seen after nimodipine treatment (SP-60-nimo). The microvascular lumen was consistently narrower in the hypertensive animals than in the normotensive controls, which neither nimodipine nor nifedipine treatment could noticeably influence. When capillary diameters were related to SBP of the individual rats, a negative correlation was established. The density of capillaries considerably varied but when the three WKY-60 groups and the three SP-60 groups were combined, an increased number of capillary profiles was detected in the given cortical area in the hypertensive animals. The correlation of capillary number per area unit with SBP did not reveal clear correspondence with an elevated SBP.
Discussion
Here we have assessed ultrastructural damage of rat cerebrocortical capillaries under chronic hypertensive conditions. The morphological abnormalities described in this study, namely fibrosis and BMT were also identified in larger brain vessels in hypertensive humans (Roggendorf et al., 1998) . Similar microvascular abnormalities were reported previously in the cerebral cortex of aging, spontaneously hypertensive rats, which was, however, restricted to a qualitative description of capillary pathology (Knox et al., 1980) . The present study provides quantitative data, which show that BMT and collagen deposits occur considerably more frequently in aging hypertensive rats than in normotensive age-matched controls. Moreover, such vascular irregularities were not increased in 60 weeks old normotensive rats when compared to a 40 weeks old normotensive group. On the other hand microvascular BMT and fibrosis markedly increased in 60 weeks old hypertensive animals compared to 40 weeks old SHR-SP rats. Based on this finding, it may be concluded that hypertension accelerates capillary damage in the brain.
Our results also indicate that chronic nifedipine or nimodipine treatment can prevent the progression of capillary wall damage in the rat cerebral cortex. It is known that dihydropyridines decrease blood pressure by binding to L-type calcium channels on vascular smooth muscle cells and inhibit vascular contractility (Katz et al., 1985; Fleckenstein and Fleckenstein-Grun, 1988; Alborch et al., 1995) , which, in turn, gives rise to vasodilatation and reduced vascular resistance (Van Zwieten and Pfaffendorf, 1993). However, the two drugs have selective effects: varying doses of nifedipine have been shown to consistently decrease blood pressure while nimodipine action on tension appeared to be concentration dependent (Grabowski and Johansson, 1985; Freedman and Waters, 1987 ; Scriabine and van den Kerckhoff, 1988; Liu et al., 1989; Frohlich, 1991) . At the dose used in the present study, only nifedipine, but not nimodipine decreased SBP. Although both compounds improved the condition of cerebral capillaries in a similar fashion, only the nifedipinemediated microvascular protection correlated with decreasing SBP while nimodipine action was independent of pressure. Thus, the processes underlying the protective effect of the two drugs on cortical capillaries must be based on more than just lowering blood pressure.
The location of L-type calcium channels in the microvascular domain, which are the principal targets of nimodipine and nifedipine, may offer further explanations for the different protective mechanisms of the two drugs. The primary building blocks of capillaries are the endothelial cells, which seem not to be endowed with L-type channels, although the occurrence of the L-type channels on the endothelium is a matter of conflicting evidence.
Preparations of isolated bovine vessels or rat pulmonary artery indicated either the presence (Bossu et al., 1992; Murphy et al., 1994) or the absence (Harrison et al., 1991) of L-type calcium channels on endothelial cells but a generally promoted concept claims the latter conclusion (Alborch et al., 1995) . Accepting the lack of L-type channels on the endothelial surface, it is doubtful that nifedipine or nimodipine can directly act on the endothelium.
Nifedipine was described to block cellular calcium influx by binding to L-type calcium channels on peripheral vascular smooth muscle. By doing so, nifedipine attenuates the contractility of these vascular elements, which leads to decreased blood pressure (Katz et al., 1985; Fleckenstein and Fleckenstein-Grun, 1988; Alborch et al., 1995) . Thus, it seems attractive to reason that vascular protection in our nifedipine treated animals was achieved by reducing SBP, which assumption would agree with the correlation found between the percentage of intact vessels and SBP. However, the finding that nimodipine treatment achieved similar microvascular protection in our paradigm without lowering SBP asks for another explanation. Since nimodipine and nifedipine were described to penetrate the brain (Janicki et al., 1988; Scriabine and van den Kerckhoff, 1988; Scriabine et al., 1989; Larkin et al., 1992; Uchida et al., 1997) where they can block calcium influx at neuronal elements (Scriabine et al., 1989; Schuurman and Traber, 1994; Disterhoft et al., 1996) , the mechanisms stimulated by the drugs to preserve capillary integrity may very well lie at CNS level. Astrocytes are closely related to cerebral microvessels and participate in the formation and maintenance of the BBB. The astrocytic endfeet embrace the vascular basement membrane and were described to be able to regulate the intracerebral vascular tone and cerebral blood flow indicated by the expression of serotonergic and cholinergic receptors on the perivascular endfeet (Janzer, 1993; Cohen et al., 1996; Luiten et al., 1996; Cohen et al., 1999; Elhusseiny et al., 1999; Pardridge, 1999) . Furthermore, astrocytes were also reported to secrete basement membrane components (Zarow et al., 1997) .
The calcium homeostasis of brain cells including astrocytes can be compromised in ischemia. A mild, chronic ischemic condition in hypertension may emerge from a reduced cerebral blood flow (CBF) reported in hypertensive patients as well as hypertensive rats Cerebral hypoperfusion, thus also occurring in hypertension, is known to impose a mild ischemic condition. The metabolic effects of reduced cerebral blood flow were studied in animal models of chronic bilateral carotid artery occlusion. Using this hypoperfusion model, De la Torre and co-workers reported, for example, a decreased cytochrome oxidase activity in neuronal mitochondria suggesting a mild ischemic condition in chronic cerebral hypoperfusion (de la Torre et al., 1997), which implies an increased intracellular calcium concentration that can impose harmful effects on mitochondrial function. Furthermore, the elevated calcium concentration is known to activate detrimental metabolic cascades and is accompanied by free radical generation (Siesjo et al., 1995) . The calcium-generated synthesis and accumulation of the easily translocating NO and its toxic products (Beckman, 1991; Love, 1999) can attack the integrity of the BBB: it may cause astrocytic dysfunction [43] and increased endothelial permeability (Wei et al., 1986; Imaizumi et al., 1996 , Lagrange et al., 1999 . The here presented microvascular pathology in SHR-SP animals can be associated with such a chain of events. Nimodipine treatment can supposedly prevent the intracellular calcium accumulation, thus moderating free radical production (Zhu et al., 1999) and consequent cerebral capillary injury.
The possibility that a decreased CBF-induced, mild but persistent ischemic condition would contribute to the capillary damage seen here could be reflected by changes in capillary density since cerebral ischemia has been shown to promote microvascular proliferation. For example, hypoxia has been demonstrated to lead to the enlargement and proliferation of the microvascular endothelial cells and a consequent increase of cerebral capillary density (Harik et al., 1995) . Capillary density was also reported to correlate with the metabolic rate for glucose (Hudetz, 1997) . Our data indicate a hypertension-related decrease in capillary diameter and an increase of capillary density in the cortical region investigated. These observations can raise the following assumptions. Considering that the endothelial cells and pericytes presumably possess contractile properties (Kelley et al., 1987 ), a generally narrower capillary lumen may reflect vasoconstriction typically associated with hypertension. The decreased capillary diameter can be responsible for a lower CBF, which would give rise to a mild, chronic ischemia represented by the elevated capillary density. Of course, such hypothesis can only be fully appreciated if the detection of typical indicators of ischemia (reduced glucose utilization and oxygen consumption) gives support to the vascular observations. Nevertheless, a persisting but moderate ischemic condition may well be causal to the here-described capillary damage, which could be prevented by dihydropyridines.
In summary, it has been shown in this study that hypertension can accelerate agerelated, ultrastructural capillary malformations. Microvascular degeneration appears in the form of vascular basement membrane pathology, such as BMT and fibrosis. Chronic treatment with dihydropiridine drugs, in this case with nimodipine and nifedipine can prevent the progression of microvascular damage by reducing the ratio of cerebral capillaries featuring BMT. Thus, in addition to the well-described beneficial effects of dihydropiridines on neuronal networks, nimodipine and nifedipine have been shown to improve the condition of cerebral capillaries in chronic hypertension. The underlying mechanism of the process may be related to an increase in CBF, which leads to an improved neural regulation of cerebrovascular function. The precise chain of events, however, is still to be elucidated.
